CU Anschutz Department of Pharmacology
@cupharmacology.bsky.social did:plc:yxuvo4hieifcpprffxyxvvfx
Our mission is to advance the field of pharmacology through innovative and impactful research and by training the next generation of scientists at the University of Colorado Anschutz Medical Campus. https://linktr.ee/cupharmacology
En Bluesky desde el
- Seguidores
- 135
- Siguiendo
- 58
- Posts
- 155
- Días en rankings
- 0
Resumen
CU Anschutz Department of Pharmacology (@cupharmacology.bsky.social) es un usuario de Bluesky que se unió el 21 noviembre 2024. Tiene 135 seguidores, sigue a 58 cuentas y ha publicado 155 posts.
Apariciones en rankings
Los mejores días en que los posts de esta cuenta entraron en la lista diaria de Debya.
Esta cuenta aún no ha aparecido en un ranking diario.
Posts que le gustaron recientemente
Me gusta públicos de la red Bluesky.
Thomas Flaig (@tomflaigmd.bsky.social), MD, Vice Chancellor for Research at CU Anschutz, continues to lead global bladder cancer treatment guidelines through his role at NCCN. At the NCCN Annual Conference, he outlined new therapies, research, and practical insights to improve patient care. (1/6)
Ver postKudos to four CCTSI program leaders recognized for excellence in #research, #mentorship, and leadership at @cuanschutz.bsky.social and nationally. We’re proud to work with Drs. Natalie Nokoff, Natalie Serkova, Janine Higgins & Paul MacLean. Congrats! 👏 @kmess44.bsky.social, @CCOS-CTSA.bsky.social
Ver postDendritic arbors provide neuroscience with an ideal opportunity to study how individual neurons interact with their broader circuitry and are the field’s best bet to bridge cellular and systems neuroscience, writes @justinkohare.bsky.social. #neuroskyence www.thetransmitter.org/dendrites/de...
Ver postEndocrine Research Conference: Dr Michael Oliphant presented really cool work on understanding breast cancer development and treatment. @cupharmacology.bsky.social
Ver postContenido no disponible
Ver post
Cuentas que bloquea
En Bluesky los bloqueos son registros públicos.
Esta cuenta no bloquea a nadie.